What's new

Human medicines European public assessment report (EPAR): Rezolsta, darunavir,cobicistat, Date of authorisation: 19/11/2014, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Rezolsta, darunavir,cobicistat, Date of authorisation: 19/11/2014, Revision: 18, Status: Authorised

Apr 14, 2025 - 15:58
 0
Human medicines European public assessment report (EPAR): Rezolsta, darunavir,cobicistat, Date of authorisation: 19/11/2014, Revision: 18, Status: Authorised
Human medicines European public assessment report (EPAR): Rezolsta, darunavir,cobicistat, Date of authorisation: 19/11/2014, Revision: 18, Status: Authorised
Read More

Tags:

Previous Article

Ironwood rethinks options after FDA demands another phase 3 trial for GI drug

Next Article

Trove acquires German resale platform Reverse.supply

Related Posts

Human medicines European public assessment report (EPAR): Clopidogrel Viatris (previously Clopidogrel Taw Pharma), clopidogrel, Date of authorisation: 16/10/2009, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 15, 2025  0

EMEA-003350-PIP01-23

EMEA-003350-PIP01-23

Feb 19, 2025  0

Medicine shortage communications (MSC)

Medicine shortage communications (MSC)

Apr 7, 2025  0